![]() |
市場調查報告書
商品編碼
1938245
發酵原料市場-全球產業規模、佔有率、趨勢、機會及預測(按類型、形態、製程、應用、地區及競爭格局分類,2021-2031年)Fermented Ingredients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Type, By Form, By Process, By Application, By Region & Competition, 2021-2031F |
||||||
全球發酵原料市場預計將從 2025 年的 470.8 億美元成長到 2031 年的 739.2 億美元,複合年成長率為 7.81%。
發酵成分,即受控微生物活動產生的代謝物或生質能,用於增強各種產品的風味、營養價值和貨架穩定性。這個市場擴張的主要驅動力是食品生產結構向天然和潔淨標示保鮮方法的轉變,以及工業界對永續蛋白質替代品日益成長的需求。這些因素並非曇花一現,而是源自於對長期供應鏈永續性的需求以及消費者對合成添加劑的抵制,從而需要對食品生產配方進行永久性調整。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 470.8億美元 |
| 市場規模:2031年 | 739.2億美元 |
| 複合年成長率:2026-2031年 | 7.81% |
| 成長最快的細分市場 | 乾燥 |
| 最大的市場 | 北美洲 |
然而,該產業面臨許多挑戰,包括擴大發酵基礎設施所需的高額資本投入,以及難以應對全球範圍內針對新型原料的碎片化法規結構。這些障礙會延長研發週期,並阻礙精準發酵等新興技術的商業性化。儘管存在這些營運方面的障礙,但投資環境正在改善。根據良好食品研究所(Good Food Institute)的數據顯示,2023年積極投資發酵行業的投資者數量增加了22%。
消費者對益生菌和消化健康解決方案的需求迅速成長,正在從根本上重塑發酵成分市場,使其從單純的防腐劑躍升為重要的功能性成分。這一轉變源於消費者對微生物群在整體健康中作用的認知不斷加深,推動了將發酵解決方案融入複雜的醫療和飲食方案的趨勢。凱瑞集團於2025年6月進行的一項消費者態度調查也印證了這一趨勢,調查發現,69%的受訪者表示,同時服用益生菌補充劑帶來的消化健康益處是他們繼續服用GLP-1類藥物的原因之一。這表明,發酵成分正成為現代藥物療法的重要輔助手段,其商業性應用範圍也已擴展到傳統食品之外。
同時,儘管進入門檻很高,但用於生產替代蛋白的精準發酵技術的快速發展正推動著大規模的產業投資。這項技術無需依賴畜牧業即可生產生物同源蛋白,有效滿足了永續性,但它也需要大規模的基建投入。該行業持續吸引強勁的資本流入,以支持其擴張進程。根據良好食品研究所 (Good Food Institute) 2025 年 5 月發布的《行業趨勢報告:發酵》顯示,該行業展現了強大的財務韌性,截至 2024 年已累計獲得 6.51 億美元的私人融資。為了將這些資金轉化為生產能力,各公司正積極投資於實體基礎設施建設,例如 Revelation Labs 公司於 2025 年 1 月發行了 5,050 萬美元的股票收購權,用於完成其位於印第安納州的商業規模生物製造工廠的建設。
全球發酵原料市場受到建造和擴大發酵基礎設施所需高額資本投入的嚴重限制。與其他對實體資產需求較低的產業不同,發酵技術在產生可觀收益之前,需要對生物反應器、下游加工設備和專用設施進行大量前期投資。這一資金壁壘阻礙了許多公司從試驗規模轉向商業化生產,造成產能不足,阻礙了創新技術進入市場。因此,新型原料的供應受到限制,導致其單位成本相對於傳統商品而言被人為地抬高。
基礎設施瓶頸問題因投資環境趨緊而進一步加劇,這限制了資產密集型計劃所需的資金流動。資金不足導致企業無法建造大規模生產設施,也無法在價格上與動物性和合成替代品競爭。根據良好食品研究所(Good Food Institute)的數據顯示,2024年發酵產業的總資金籌措僅為6.51億美元,凸顯出相對於發展全球基礎設施所需的龐大資源而言,該產業的資金投入十分有限。資金短缺直接減緩了新產能的建設速度,並阻礙了發酵衍生原料的廣泛商業化。
將生物發酵成分融入「營養美容品」和護膚產品中,正從根本上改變個人護理行業,以永續的高效生物等效物取代合成活性成分。製造商正利用精準發酵技術來設計特定分子,例如低分子量透明質酸,這些分子能夠更好地滲透肌膚,同時顯著降低資源消耗。生物技術與美容的融合,為滿足「潔淨標示」的要求開闢了一條可擴展的途徑,既不影響產品性能,也不消耗自然資源。根據奇華頓活性美容公司2024年1月發布的新聞稿,該公司精準發酵成分PrimalHyal 50 Life與傳統生產方法相比,可將環境影響降低91%。
同時,市場正經歷從活性益生菌菌株到穩定後生元成分的重大轉變,從而克服了低溫運輸配送的物流限制。與必須維持活性的益生菌不同,後生元由非活性微生物和生物活性代謝物組成,即使在高溫加工和長期儲存條件下也能保持其有效性。這使得它們能夠被添加到各種常溫保存的產品中,例如烘焙點心和飲料。這種轉變使得品牌能夠將以往僅限於冷藏乳製品的微生物組益處作為功能性成分添加到主流食品中。根據ADM 2024年10月的一項消費者態度調查,89%的美國受訪者表示,在了解後生元的健康益處後,他們願意嘗試含有後生元的產品,這印證了這種功能性變革的商業性潛力。
The Global Fermented Ingredients Market is projected to grow from USD 47.08 Billion in 2025 to USD 73.92 Billion by 2031, registering a CAGR of 7.81%. Fermented ingredients, which consist of metabolic byproducts or biomass produced through controlled microbial activity, are utilized to improve flavor, nutritional value, and shelf-stability across various applications. This market expansion is primarily driven by a structural shift toward natural, clean-label preservation methods and the rising industrial demand for sustainable protein alternatives. These drivers are not merely transient trends but are rooted in a need for long-term supply chain sustainability and consumer rejection of synthetic additives, necessitating permanent adjustments in food manufacturing formulations.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 47.08 Billion |
| Market Size 2031 | USD 73.92 Billion |
| CAGR 2026-2031 | 7.81% |
| Fastest Growing Segment | Dry |
| Largest Market | North America |
However, the sector faces a significant challenge regarding the high capital expenditure required to scale fermentation infrastructure and the difficulty of navigating fragmented global regulatory frameworks for novel ingredients. These hurdles can extend development timelines and impede the commercial viability of emerging technologies such as precision fermentation. Despite these operational barriers, the investment landscape is broadening; according to the Good Food Institute, the number of unique investors actively funding the fermentation sector increased by 22% in 2023.
Market Driver
The surge in consumer demand for probiotics and digestive health solutions is fundamentally reshaping the fermented ingredients market, elevating these components from simple preservatives to essential functional agents. This shift is driven by a deepening consumer understanding of the microbiome's role in systemic wellness, leading to the integration of fermented solutions into complex medical and dietary regimens. Highlighting this trend, a June 2025 consumer perception study by Kerry Group found that 69% of participants attributed their continued use of GLP-1 medications to the digestive health benefits provided by concurrent probiotic supplementation, indicating that fermented ingredients are becoming critical adjuncts to modern pharmaceutical therapies and expanding their commercial application beyond traditional food products.
Simultaneously, the rapid expansion of precision fermentation for alternative proteins is catalyzing significant industrial investment despite high entry barriers. This technology enables the production of bio-identical proteins without animal agriculture, effectively addressing sustainability mandates while necessitating substantial infrastructure development. The sector continues to attract robust capital inflows to support this scaling process; according to the Good Food Institute's 'State of the Industry Report: Fermentation' from May 2025, the sector demonstrated financial resilience by raising $651 million in total private funding throughout 2024. To convert this capital into operational capacity, companies are aggressively funding physical infrastructure, as evidenced by Liberation Labs securing $50.5 million in convertible note funding in January 2025 to finalize its commercial-scale biomanufacturing facility in Indiana.
Market Challenge
The Global Fermented Ingredients Market is critically impeded by the high capital expenditure required to establish and scale fermentation infrastructure. Unlike sectors with low physical asset requirements, fermentation necessitates massive upfront investment in bioreactors, downstream processing equipment, and specialized facilities before meaningful revenue can be generated. This financial barrier prevents many companies from transitioning from pilot scale to commercial production, creating a bottleneck where innovative technologies fail to reach the market due to a lack of manufacturing capacity, consequently keeping the supply of novel ingredients constrained and unit costs artificially high compared to conventional commodities.
This infrastructure bottleneck is exacerbated by a tightening investment climate that restricts the flow of capital needed for such asset-heavy projects. Without sufficient funding, companies cannot construct the large-scale facilities necessary to achieve price parity with animal-based or synthetic alternatives. According to the Good Food Institute, the fermentation sector attracted $651 million in total funding in 2024, a figure that highlights a constrained environment relative to the substantial resources required for global infrastructure build-out. This shortfall directly slows the pace at which new capacity can be brought online and stalls the broader commercialization of fermentation-derived ingredients.
Market Trends
The integration of bio-fermented ingredients in "nutri-cosmetics" and skincare is fundamentally altering the personal care sector by replacing chemically synthesized actives with sustainable, high-efficacy bio-equivalents. Manufacturers are increasingly utilizing precision fermentation to engineer specific molecules, such as low-molecular-weight hyaluronic acid, which offer superior skin penetration while drastically lowering resource consumption. This convergence of biotechnology and beauty creates a scalable pathway to meet "clean label" demands without compromising performance or depleting natural resources; according to a January 2024 corporate press release from Givaudan Active Beauty, its precision-fermented ingredient PrimalHyal 50 Life achieved a 91% reduction in environmental impact compared to conventional production methods.
Simultaneously, the market is witnessing a decisive shift from live probiotic strains to stable postbiotic ingredient formulations, overcoming the logistical limitations of cold-chain distribution. Unlike probiotics, which require viability preservation, postbiotics consist of inanimate microorganisms and bioactive metabolites that remain effective under high-heat processing and extended storage conditions, enabling their incorporation into diverse shelf-stable applications like baked goods and beverages. This transition allows brands to functionalize mainstream food products with microbiome benefits previously restricted to chilled dairy. According to an ADM consumer perception study from October 2024, 89% of participants in the United States expressed openness to trying products containing postbiotics based on their perceived health benefits, validating the commercial potential of this functional evolution.
Report Scope
In this report, the Global Fermented Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Fermented Ingredients Market.
Global Fermented Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: